We are live on ! Find out more
PAS

Point72 Asia (Singapore) Portfolio holdings

AUM $646M
1-Year Est. Return 35.24%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+35.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$563M
AUM Growth
+$182M
Cap. Flow
+$137M
Cap. Flow %
24.39%
Top 10 Hldgs %
22.34%
Holding
1,336
New
504
Increased
174
Reduced
170
Closed
483

Sector Composition

Rank Sector Weight
1 Technology 15.57%
2 Financials 14.01%
3 Industrials 13.21%
4 Communication Services 11.81%
5 Healthcare 11.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCT icon
776
Arcturus Therapeutics
ARCT
$200M
$13.1K ﹤0.01%
+1,005
New +$11.9K
RCKT icon
777
Rocket Pharmaceuticals
RCKT
$397M
$13.1K ﹤0.01%
+5,335
New +$27K
FBP icon
778
First Bancorp
FBP
$4.42B
$12.9K ﹤0.01%
620
-9,114
-94% -$179K
OVID icon
779
Ovid Therapeutics
OVID
$489M
$12.7K ﹤0.01%
+38,382
New +$11.6K
IGMS
780
DELISTED
IGM Biosciences
IGMS
$12.5K ﹤0.01%
+11,133
New +$13.6K
HBI
781
DELISTED
Hanesbrands
HBI
$12.5K ﹤0.01%
+2,719
New +$13.1K
SMXT icon
782
Solarmax Technology
SMXT
$21.1M
$12.3K ﹤0.01%
+11,262
New +$12.8K
ASIX icon
783
AdvanSix
ASIX
$438M
$12.1K ﹤0.01%
+511
New +$11.6K
HBIO icon
784
Harvard Bioscience
HBIO
$28.8M
$12.1K ﹤0.01%
+2,724
New +$11.4K
USLM icon
785
United States Lime & Minerals
USLM
$3.45B
$11.9K ﹤0.01%
+119
New +$11.6K
LILAK icon
786
Liberty Latin America Class C
LILAK
$1.65B
$11.6K ﹤0.01%
+2,054
New +$10.1K
CLDX icon
787
Celldex Therapeutics
CLDX
$3.37B
$11.5K ﹤0.01%
566
-1,232
-69% -$24K
ALXO icon
788
ALX Oncology
ALXO
$285M
$11.5K ﹤0.01%
+27,709
New +$14K
SLQT icon
789
SelectQuote
SLQT
$123M
$11.5K ﹤0.01%
+4,814
New +$12.6K
LBTYK icon
790
Liberty Global Class C
LBTYK
$3.41B
$11.2K ﹤0.01%
+1,090
New +$11.3K
GBIO
791
DELISTED
Generation Bio
GBIO
$11.2K ﹤0.01%
+3,497
New +$13.5K
PENG
792
Penguin Solutions Inc
PENG
$2.83B
$11.2K ﹤0.01%
+564
New +$10.2K
SOHU
793
Sohu.com
SOHU
$376M
$10.8K ﹤0.01%
+810
New +$8.58K
KRO icon
794
KRONOS Worldwide
KRO
$977M
$10.7K ﹤0.01%
+1,723
New +$11.8K
DNUT icon
795
Krispy Kreme
DNUT
$542M
$10.7K ﹤0.01%
+3,666
New +$12.8K
FBLG icon
796
FibroBiologics
FBLG
$6.53M
$10.3K ﹤0.01%
+825
New +$14.9K
GOTU icon
797
Gaotu Techedu
GOTU
$444M
$10.2K ﹤0.01%
2,820
+1,431
+103% +$4.91K
IDYA icon
798
IDEAYA Biosciences
IDYA
$3.54B
$10K ﹤0.01%
+476
New +$9.13K
TLRY icon
799
Tilray
TLRY
$602M
$9.8K ﹤0.01%
+2,409
New +$10.9K
AZZ icon
800
AZZ Inc
AZZ
$4.58B
$9.54K ﹤0.01%
+101
New +$8.91K

Similar funds

Point72 Asia (Singapore)'s Q2 2025 Portfolio in Review

As of Q2 2025, Point72 Asia (Singapore) held 1,336 positions worth $563M, up 48% from $381M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Point72 Asia (Singapore) deployed $137M of net new capital in Q2 2025, opening 504 new positions and adding to 174 existing holdings. Its largest new stake was Cheniere Energy: 53,973 shares worth $13.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Credo Technology Group, an estimated $15.7M trimmed.

  • Point72 Asia (Singapore)'s largest Q2 2025 buy was Cheniere Energy: 53,973 shares worth $13.1M.
  • Point72 Asia (Singapore) added most to Alphabet (Google) Class C in Q2 2025, an estimated $17.4M increase.
  • Point72 Asia (Singapore)'s biggest Q2 2025 reduction was Credo Technology Group, cutting an estimated $15.7M.
  • Point72 Asia (Singapore) fully exited Blackrock in Q2 2025, selling an estimated $12M.
  • Point72 Asia (Singapore)'s ten largest holdings make up 22% of its $563M portfolio in Q2 2025.
  • Point72 Asia (Singapore) opened 504 new positions and closed 483 in Q2 2025.
  • Point72 Asia (Singapore)'s portfolio value rose 48% quarter-over-quarter to $563M.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.